Page last updated: 2024-08-22

tranylcypromine and Depressive Disorder, Major

tranylcypromine has been researched along with Depressive Disorder, Major in 25 studies

Research

Studies (25)

TimeframeStudies, this research(%)All Research%
pre-19905 (20.00)18.7374
1990's1 (4.00)18.2507
2000's11 (44.00)29.6817
2010's7 (28.00)24.3611
2020's1 (4.00)2.80

Authors

AuthorsStudies
Bauer, M; Findeis, H; Ludwig, VM; Ritter, P; Rucker, J; Sauer, C; Young, AH1
Freudenmann, RW; Gahr, M; Kölle, MA; Schönfeldt-Lecuona, C2
Schene, A; van den Born, BJ; van der Hoeven, N; Visser, I1
Deliyannides, DA; McGrath, PJ; Stewart, JW1
Bosanac, P; Castle, D; Menkes, D1
Ribeiro, RB; Rigonatti, SP; Rosa, MA1
Gitlin, MJ; Rim, CL1
Boerner, RJ; Lühring, F1
ANDERSON, R; BELLVILLE, T; JANECEK, J; SCHIELE, BC1
LINGL, FA1
KEARNEY, TR2
HEISTAD, G; MENA, A; SCHIELE, BC; SHARPLEY, P1
Clemons, WE; Makela, E; Young, J1
Bhalerao, S; Demarchi, R; Krishnadev, N; Kundhal, PS; Sockalingam, S1
Gorman, JM1
Masand, PS; Pae, CU; Patkar, AA1
Valenstein, M1
Biggs, MM; Davis, L; Fava, M; Luther, JF; McGrath, PJ; Niederehe, G; Nierenberg, AA; Rush, AJ; Shores-Wilson, K; Stewart, JW; Thase, ME; Trivedi, MH; Warden, D; Wisniewski, SR1
Bruijn, JA; Tulen, JH; van den Broek, WW; Volkers, AC1
Rush, AJ1
Carroll, BT; Goforth, HW1
Stewart, JT1
Bommelé, JJ; de Koning, J; Jansen, GS; Pennings, EJ; Verkes, RJ; Vermeij, P1

Reviews

4 review(s) available for tranylcypromine and Depressive Disorder, Major

ArticleYear
Intoxications with the monoamine oxidase inhibitor tranylcypromine: an analysis of fatal and non-fatal events.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2013, Volume: 23, Issue:11

    Topics: Depressive Disorder, Major; Dose-Response Relationship, Drug; Humans; Monoamine Oxidase Inhibitors; Tranylcypromine

2013
MAOIs - does the evidence warrant their resurrection?
    Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists, 2016, Volume: 24, Issue:4

    Topics: Anxiety Disorders; Bipolar Disorder; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Humans; Monoamine Oxidase Inhibitors; Phenelzine; Phobia, Social; Randomized Controlled Trials as Topic; Tranylcypromine

2016
Withdrawal and discontinuation phenomena associated with tranylcypromine: a systematic review.
    Pharmacopsychiatry, 2013, Volume: 46, Issue:4

    Topics: Adult; Aged; Antidepressive Agents; Cohort Studies; Delirium; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Monoamine Oxidase Inhibitors; Thrombocytopenia; Tranylcypromine; Young Adult

2013
Transdermal selegiline: the new generation of monoamine oxidase inhibitors.
    CNS spectrums, 2006, Volume: 11, Issue:5

    Topics: Administration, Cutaneous; Depressive Disorder, Major; Drug Interactions; Humans; Monoamine Oxidase Inhibitors; Phenelzine; Selegiline; Tranylcypromine

2006

Trials

4 trial(s) available for tranylcypromine and Depressive Disorder, Major

ArticleYear
How treatable is refractory depression?
    Journal of affective disorders, 2014, Volume: 167

    Topics: Adult; Antidepressive Agents; Central Nervous System Stimulants; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Dextroamphetamine; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Lithium Compounds; Male; Middle Aged; Nortriptyline; Phenelzine; Tranylcypromine; Treatment Outcome

2014
Keeping our eyes on STAR*D.
    The American journal of psychiatry, 2006, Volume: 163, Issue:9

    Topics: Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Drug Therapy, Combination; Humans; Lithium; Mianserin; Mirtazapine; Placebos; Research Design; Tranylcypromine; Treatment Outcome; Triiodothyronine; Venlafaxine Hydrochloride

2006
Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report.
    The American journal of psychiatry, 2006, Volume: 163, Issue:9

    Topics: Adult; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Female; Humans; Interviews as Topic; Male; Mianserin; Middle Aged; Mirtazapine; Psychiatric Status Rating Scales; Tranylcypromine; Treatment Outcome; Venlafaxine Hydrochloride

2006
Sustained effects of phenelzine and tranylcypromine on orthostatic challenge in antidepressant-refractory depression.
    Journal of clinical psychopharmacology, 2006, Volume: 26, Issue:5

    Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Blood Pressure; Depressive Disorder, Major; Double-Blind Method; Drug Resistance; Female; Fluvoxamine; Humans; Hypotension, Orthostatic; Imipramine; Male; Middle Aged; Monoamine Oxidase Inhibitors; Phenelzine; Psychiatric Status Rating Scales; Tranylcypromine; Treatment Outcome

2006

Other Studies

17 other study(ies) available for tranylcypromine and Depressive Disorder, Major

ArticleYear
Cardiovascular Effects of Combining Subcutaneous or Intravenous Esketamine and the MAO Inhibitor Tranylcypromine for the Treatment of Depression: A Retrospective Cohort Study.
    CNS drugs, 2021, Volume: 35, Issue:8

    Topics: Administration, Intravenous; Adult; Aged; Antidepressive Agents; Blood Pressure; Cohort Studies; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Dose-Response Relationship, Drug; Drug Interactions; Female; Heart Rate; Humans; Injections, Subcutaneous; Ketamine; Male; Middle Aged; Monoamine Oxidase Inhibitors; Retrospective Studies; Tranylcypromine; Young Adult

2021
Severe hypertension related to caffeinated coffee and tranylcypromine: a case report.
    Annals of internal medicine, 2014, May-06, Volume: 160, Issue:9

    Topics: Caffeine; Coffee; Depressive Disorder, Major; Drug Interactions; Humans; Hypertension; Male; Middle Aged; Monoamine Oxidase Inhibitors; Tranylcypromine

2014
Electroconvulsive therapy and monoamine oxidase inhibitors.
    Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999), 2008, Volume: 30, Issue:4

    Topics: Adult; Combined Modality Therapy; Depressive Disorder, Major; Electroconvulsive Therapy; Female; Humans; Monoamine Oxidase Inhibitors; Tranylcypromine

2008
Ziprasidone, monoamine oxidase inhibitors, and the serotonin syndrome.
    Journal of clinical psychopharmacology, 2010, Volume: 30, Issue:4

    Topics: Adult; Depressive Disorder, Major; Drug Interactions; Female; Humans; Monoamine Oxidase Inhibitors; Piperazines; Serotonin Antagonists; Serotonin Syndrome; Thiazoles; Tranylcypromine

2010
[Tranylcypromine for chronic therapy-resistant agoraphobia with panic disorder and recurrent depressive disorder].
    Psychiatrische Praxis, 2010, Volume: 37, Issue:7

    Topics: Aged; Agoraphobia; Ambulatory Care; Anti-Anxiety Agents; Antidepressive Agents; Cognitive Behavioral Therapy; Combined Modality Therapy; Comorbidity; Depressive Disorder, Major; Drug Resistance; Follow-Up Studies; Humans; Implosive Therapy; Male; Panic Disorder; Patient Readmission; Psychoanalytic Therapy; Tranylcypromine; Treatment Outcome

2010
THE EFFECTS OF WITHDRAWAL OF TRIFLUOPERAZINE ON PATIENTS MAINTAINED ON THE COMBINATION OF TRANYLCYPROMINE AND TRIFLUOPERAZINE: A DOUBLE-BLIND STUDY.
    Current therapeutic research, clinical and experimental, 1963, Volume: 5

    Topics: Bipolar Disorder; Depressive Disorder, Major; Double-Blind Method; Mental Disorders; Psychotic Disorders; Schizophrenia; Toxicology; Tranylcypromine; Trifluoperazine

1963
COMBINED DRUG THERAPY COMPARED WITH ELECTRIC SHOCK IN PSYCHOTIC DEPRESSIONS.
    The American journal of psychiatry, 1964, Volume: 120

    Topics: Bipolar Disorder; Depression; Depressive Disorder; Depressive Disorder, Major; Electroconvulsive Therapy; Humans; Psychotic Disorders; Tranylcypromine; Trifluoperazine

1964
TREATMENT OF ATYPICAL DEPRESSION DEPRESSION WITH LIBRIUM AND PARNATE.
    Diseases of the nervous system, 1964, Volume: 25

    Topics: Anxiety; Anxiety Disorders; Bipolar Disorder; Chlordiazepoxide; Dementia; Depression; Depressive Disorder, Major; Drug Therapy; Neurotic Disorders; Psychotic Disorders; Schizophrenia; Toxicology; Tranylcypromine

1964
TREATMENT OF ATYPICAL DEPRESSION WITH LIBRIUM AND PARNATE.
    Diseases of the nervous system, 1964, Volume: 25

    Topics: Anxiety; Bipolar Disorder; Chlordiazepoxide; Dementia; Depression; Depressive Disorder, Major; Drug Therapy; Mental Disorders; Neurotic Disorders; Psychology; Psychotic Disorders; Schizophrenia; Toxicology; Tranylcypromine

1964
A COMPARISON OF PARGYLINE AND TRANYLCYPROMINE WITH AND WITHOUT THE ADDITION OF TRIFLUOPERAZINE: A DOUBLE-BLIND STUDY.
    Current therapeutic research, clinical and experimental, 1964, Volume: 6

    Topics: Biomedical Research; Brain; Brain Damage, Chronic; Depressive Disorder, Major; Double-Blind Method; Drug Therapy; Intellectual Disability; Mental Disorders; Paranoid Disorders; Pargyline; Psychotic Disorders; Schizophrenia; Tranylcypromine; Trifluoperazine

1964
Concomitant use of modafinil and tranylcypromine in a patient with narcolepsy: a case report.
    Sleep medicine, 2004, Volume: 5, Issue:5

    Topics: Benzhydryl Compounds; Blood Pressure; Cataplexy; Central Nervous System Stimulants; Comorbidity; Depressive Disorder, Major; Disorders of Excessive Somnolence; Drug Therapy, Combination; Female; Humans; Middle Aged; Modafinil; Monoamine Oxidase Inhibitors; Narcolepsy; Tranylcypromine

2004
Monoamine oxidase inhibitors and subarachnoid hemorrhage.
    Canadian journal of psychiatry. Revue canadienne de psychiatrie, 2004, Volume: 49, Issue:8

    Topics: Depressive Disorder, Major; Humans; Male; Middle Aged; Monoamine Oxidase Inhibitors; Subarachnoid Hemorrhage; Tranylcypromine

2004
Leading the way: advances in the diagnosis, treatment, and management of neuropsychiatric illnesses.
    CNS spectrums, 2006, Volume: 11, Issue:5

    Topics: Administration, Cutaneous; Administration, Topical; Brain; Depressive Disorder, Major; Humans; Mental Disorders; Monoamine Oxidase Inhibitors; Phenelzine; Psychiatry; Selegiline; Somatoform Disorders; Tranylcypromine

2006
STAR*D: what have we learned?
    The American journal of psychiatry, 2007, Volume: 164, Issue:2

    Topics: Ambulatory Care; Antidepressive Agents; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Depressive Disorder, Major; Drug Therapy, Combination; Follow-Up Studies; Humans; Lithium Compounds; Randomized Controlled Trials as Topic; Research Design; Secondary Prevention; Tranylcypromine; Treatment Outcome; Venlafaxine Hydrochloride

2007
Aripiprazole augmentation of tranylcypromine in treatment-resistant major depression.
    Journal of clinical psychopharmacology, 2007, Volume: 27, Issue:2

    Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Depressive Disorder, Major; Drug Resistance; Drug Synergism; Drug Therapy, Combination; Female; Humans; Middle Aged; Monoamine Oxidase Inhibitors; Piperazines; Quinolones; Tranylcypromine; Treatment Outcome

2007
Not all monoamine oxidase inhibitors are created equal.
    Journal of the American Geriatrics Society, 2007, Volume: 55, Issue:11

    Topics: Aged; Aged, 80 and over; Antidepressive Agents; Combined Modality Therapy; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Resistance; Electroconvulsive Therapy; Humans; Male; Monoamine Oxidase Inhibitors; Phenelzine; Recurrence; Tachyphylaxis; Tranylcypromine

2007
Tranylcypromine intoxication with malignant hyperthermia, delirium, and thrombocytopenia.
    Journal of clinical psychopharmacology, 1997, Volume: 17, Issue:5

    Topics: Adult; Antidepressive Agents; Delirium; Depressive Disorder, Major; Drug Overdose; Humans; Male; Malignant Hyperthermia; Serotonin; Suicide, Attempted; Thrombocytopenia; Tranylcypromine

1997